Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Anabaseine is a non-selective nicotinic agonist that stimulates all alpha-7 subtypes of AChRs, with a preference for skeletal muscle and brain. Additionally, it acts as a weak partial agonist at alpha-4 beta-2 nAChRs.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | Anabaseine is a non-selective nicotinic agonist that stimulates all alpha-7 subtypes of AChRs, with a preference for skeletal muscle and brain. Additionally, it acts as a weak partial agonist at alpha-4 beta-2 nAChRs. |
In vitro | Anabaseine serves as a full agonist at the α7 AChR within the central nervous system (CNS) and operates as a full agonist for α1β1?δ and α1β1γδ (Torpedo) receptors in the peripheral nervous system. Additionally, it functions as a neuromuscular agonist on the frog rectus abdominis muscle, demonstrating efficacy within a range of EC 50 values from 0.25 to 0.74 μM. |
In vivo | Anabaseine (3.6 μmol/kg; subcutaneous injection) elevates ACh levels[1]. |
Molecular Weight | 160.22 |
Formula | C10H12N2 |
CAS No. | 3471-05-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Anabaseine 3471-05-4 inhibitor inhibit